AI assistant
Sending…
Inogen Inc — Director's Dealing 2014
Oct 22, 2014
33625_dirs_2014-10-21_c14abd79-5e5b-4556-8411-e43b96a17d0b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2014-10-20
Reporting Person: Huggenberger Raymond (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-20 | Common Stock | M | 25722 | $0.60 | Acquired | 32530 | Direct |
| 2014-10-20 | Common Stock | S | 25722 | $19.8319 | Disposed | 6808 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-10-20 | Stock Option (right to buy) | $0.60 | M | 25722 | Disposed | 2019-02-10 | Common Stock (25722) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2014.
F2: Represents the weighted average share price of an aggregate total of 25,722 shares sold in the price range of $19.50 to $20.16 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
More from Inogen Inc
Regulatory Filings
2026
May 28
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3